ArticleCancer immunology, immunotherapy : CII2024

Efficacy of immune checkpoint inhibitors differs in various status of carcinoma: a study based on 29 cohorts with 3255 participants.

Chunlan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.